Ending The Global Tuberculosis Epidemic: The Role Of Patient Costs
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
TB is an important public health problem worldwide. Rates of TB are declining but not fast enough to reach targets set by the World Health Organization to end the disease by 2035. One reason why TB remains an issue is the cost of health care for patients. My research will look at the costs of TB care for patients in Papua New Guinea and will compare costs between countries. I will look at policies to protect the sick and will conduct research to determine what works best in decreasing costs.
Prevention Of Multi-drug Resistant Tuberculosis In A High Prevalence Setting: ‘Connecting The DOTS’ In Vietnam
Funder
National Health and Medical Research Council
Funding Amount
$3,382,020.00
Summary
The close contacts of people with multi-drug resistant tuberculosis (MDR-TB) have a high risk of developing the disease. The V-QUIN MDR-TB Trial will evaluate the effectiveness of an oral antibiotic (levofloxacin) in preventing drug resistant TB among infected household contacts of TB patients. Household contacts from 10 Provinces in Vietnam will be randomly allocated to receive six-months of either levofloxacin or a placebo, and then followed for two years to see if they develop tuberculosis.
Tuberculosis In The Asia-Pacific: Identification And Comparison Of Transmission Hot Spots
Funder
National Health and Medical Research Council
Funding Amount
$120,253.00
Summary
The Asia-Pacific is home to 60% of the global burden of tuberculosis and an increasing proportion of Australia's immigrant population. Although most targets relating to this disease are likely to be achieved, patterns of tuberculosis transmission in the Asia-Pacific are not fully understood and the possibility of regional hotspots exists. We aim to use mathematical techniques to examine the way in which tuberculosis is transmitted from person to person in populations within our region.
Plotting A Course To Tuberculosis Elimination In Our Lifetime
Funder
National Health and Medical Research Council
Funding Amount
$348,768.00
Summary
Tuberculosis (TB) is the world’s leading infectious killer and more than half of TB cases occur in Australia’s region. I have developed a software program and used it to simulate improved TB control in eight countries across the world. In this fellowship, I will extend this program to allow simulation of TB transmission across multiple countries. This will allow me to compare the effects of TB control programs in Australia and overseas, as well as to re-estimate the global number of TB deaths.
Improving Global Tuberculosis Control With The AuTuMN Platform
Funder
National Health and Medical Research Council
Funding Amount
$655,059.00
Summary
Tuberculosis (TB) is the world’s leading infectious killer, with the failure of global control responsible for the vast majority of Australia’s cases. Using our robustly developed software platform, we have performed several country-level studies to predict the future burden of disease and compare the impact of alternative responses to controlling the epidemic. In this project, we will extend our platform to perform simulations at the global level and answer key questions in TB control.
Use Of Statistical And Mathematical Models To Investigate Infectious Disease Transmission Dynamics To Better Inform Control Measures In Hospitals And The Community
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
Globally tuberculosis infects over 9 million people yearly. In low incidence countries TB is re-emerging, with HIV, drug resistance and migration driving this. Australia needs to examine the transmission of TB within our country and The Asia-Pacific region. This proposal will quantify the risk for importation of highly drug resistant TB into Australia and assess the factors that lead to outbreaks. Models will be informative for Australian TB policy development and contribute to regional and glob ....Globally tuberculosis infects over 9 million people yearly. In low incidence countries TB is re-emerging, with HIV, drug resistance and migration driving this. Australia needs to examine the transmission of TB within our country and The Asia-Pacific region. This proposal will quantify the risk for importation of highly drug resistant TB into Australia and assess the factors that lead to outbreaks. Models will be informative for Australian TB policy development and contribute to regional and global efforts for TB control.Read moreRead less
Injecting Drug Use, Incarceration, Infection: Investigating Opportunities For Public Health Interventions In Disadvantaged Populations
Funder
National Health and Medical Research Council
Funding Amount
$329,564.00
Summary
New knowledge required to address infectious diseases and mental illness among two disadvantaged and overlapping groups -people who inject drugs (PWID) and prisoners – will be produced: Cross sectional and longitudinal studies will examine HIV risk in specific populations; A system to track the emergence of injecting will be developed; The global scale of mental illness and TB among PWID will be determined; and how to improve coverage and delivery of TB prevention and treatment will be explored.